Md Badirujjaman

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 01, 2024
Esterase-Responsive Self-Immolative Prodrugs for the Sustained Delivery of the Anticancer Drug 5-Fluorouracil with Turn-On Fluorescence.

Md Badirujjaman, Rajkumar P Thummer, Krishna P Bhabak

|Apr 11, 2024
Inflammatory-stimuli-responsive turn-on NIR fluorogenic theranostic prodrug: adjuvant delivery of diclofenac and hydrogen sulfide attenuates acute inflammatory disorders.

Abu Sufian, Nidhi Parihar, Md Badirujjaman

|Sep 04, 2023
Dual-Stimuli-Activatable Hybrid Prodrug for the Self-Immolative Delivery of an Anticancer Agent and Hydrogen Sulfide with Turn-On Fluorescence.

Abu Sufian, Md Badirujjaman, Pallavi Barman

|Mar 31, 2023
Cysteine-responsive prodrug of the anti-cancer drug amonafide: fluorogenic adjuvant drug delivery with hydrogen sulfide (H2S).

Sulendar K Mahato, Pallavi Barman, Md Badirujjaman

Pageof 1

Frequent Collaborators

4 joint publications

Krishna P Bhabak

3 joint publications

Pallavi Barman

1 joint publications

Sulendar K Mahato

1 joint publications

Abu Sufian